news Chemotherapy alternative: research shows Chinese medicine kills cancer cells 8 September 2016 | By Niamh Louise Marriott, Digital Content Producer Compound kushen injection (CKI) has been used for years in Chinese clinics as an adjunct to western chemotherapy. Researchers used next generation...
product Bio-Rad CFX96 Touch™ Real-Time PCR Detection System 4 August 2016 | By Bio-Rad Laboratories The CFX96™ Optical Reaction Module converts the C1000 Touch™ Thermal Cycler chassis into the powerful and precise CFX96 Touch Real-Time PCR Detection System...
news The impact of antibiotic exposure on the infant microbiome 15 June 2016 | By Victoria White, Digital Content Producer An analysis of changes in the intestinal microbial population during the first three years of life has revealed some of the impacts of antibiotic exposure...
news Children with cancer to be offered gene testing in personalised treatment initiative 31 March 2016 | By Victoria White Children with cancer will be offered testing for genetic mutations in their tumours as part of an initiative to personalise children’s cancer treatment...
news CEGX closes $21 million Series B financing and appoints CEO 14 March 2016 | By Victoria White Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, has appointed Dr Geoff Smith as CEO...
news New project aims to establish genome sequencing as a clinical tool 19 October 2015 | By Victoria White Genomics has entered into a collaboration agreement in a research project focused on the translation of whole genome sequencing into clinical practice...
news In conversation – Thoughts on the current status of the sequencing industry. An interview with Jacqueline Boultwood, University of Oxford 4 September 2015 | By Oxford Global In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford, a confirmed speaker at the congress, about her thoughts on the current status of the sequencing industry...